Dr. Unnikrishnan Gopalakrishnan – Guest Editor for Jul 2021
I am delighted to be the Guest Editor for Metabolic Health Digest’s July 2021 issue. Evidence from literature suggests that obesity is a rising health...
I am delighted to be the Guest Editor for Metabolic Health Digest’s July 2021 issue. Evidence from literature suggests that obesity is a rising health...
CASE OVERVIEW DPP-4 inhibitors are an established class of oral antidiabetic agents for the treatment of type 2 diabetes. The most widely used among...
CASE OVERVIEW The ADA recognizes that overtreatment of diabetes in eldelry population is common and should be avoided. “ Deintensification (or simplification) of complex...
CASE OVERVIEW Insulin Autoimmune Syndrome (IAS)/ Hirata’s Disease (IAH) is a rare cause of hypoglycemia. Such case of 70-year old female was presented by...
In recent years studies have evaluated efficacy in β-blockers in this population of patients receiving haemodialysis to assess the mortality and cardiovascular (CV) outcomes....
Under the auspices of the Research Society for Study of Diabetes in India (RSSDI), Dr. Banshi Saboo and his team have launched a large-scale...